Apimeds appoints Dr. Susan Kramer SVP Development, Brian Peters to lead ai² division

Apimeds Pharmaceuticals US, Inc.

Dr. Susan Kramer appointed SVP of Development; 30+ years experience including 18 at Genentech.
Brian Peters joins as Head of ai² division; previously Chief Strategy & Insights Officer at Heller Agency.
CEO Erik Emerson says strengthening operational leadership is a priority since IPO.
Dr. Kramer will oversee all product development; Peters will lead ai² platform strategy and launch.
Both appointments effective July 15, 2025.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.